[Antagonizing anticoagulants in intracranial hemorrhage - step by step].

Antikoagulation antagonisieren bei intrakranieller Blutung – Schritt für Schritt.

Journal

Deutsche medizinische Wochenschrift (1946)
ISSN: 1439-4413
Titre abrégé: Dtsch Med Wochenschr
Pays: Germany
ID NLM: 0006723

Informations de publication

Date de publication:
09 2023
Historique:
medline: 18 9 2023
pubmed: 16 9 2023
entrez: 15 9 2023
Statut: ppublish

Résumé

Intravenous thrombolysis for acute ischemic stroke is an indispensable tool and current standard of care in neurology. However, until recently direct therapeutic options for intracranial hemorrhage under existing anticoagulation were not available. With the introduction of two new medications - Idarucizumab and Andexanet alfa - neurologists take a more targeted approach in treating these patients.

Identifiants

pubmed: 37714165
doi: 10.1055/a-2116-4526
doi:

Substances chimiques

Anticoagulants 0

Types de publication

English Abstract Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

1252-1258

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Felix Nägele und Maximilian Schell geben an, dass keine Interessenskonflikte bestehen Götz Thomalla hat Honorare erhalten für Vortragstätigkeiten oder als Berater von Acanadis, Alexion, Amarin, Bayer, Boehringer Ingelheim, BristolMyersSquibb/Pfizer, Daiichi Sankyo, Portola, Stryker.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH